Errors within the total laboratory testing process, from test selection to medical decision-making - A review of causes, consequences, surveillance and solutions
Croatian Society of Medical Biochemistry and Laboratory Medicine..
Laboratory analyses are crucial for diagnosis, follow-up and treatment decisions. Since mistakes in every step of the total testing process may potentially affect patient safety, a broad knowledge and systematic assessment of laboratory errors is essential for future improvement. In this review, we aim to discuss the types and frequencies of potential errors in the total testing process, quality management options, as well as tentative solutions for improvement. Unlike most currently available reviews on this topic, we also include errors in test-selection, reporting and interpretation/action of test results. We believe that laboratory specialists will need to refocus on many process steps belonging to the extra-analytical phases, intensifying collaborations with clinicians and supporting test selection and interpretation. This would hopefully lead to substantial improvements in these activities, but may also bring more value to the role of laboratory specialists within the health care setting.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:30 |
---|---|
Enthalten in: |
Biochemia medica - 30(2020), 2 vom: 15. Juni, Seite 020502 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Mrazek, Cornelia [VerfasserIn] |
---|
Links: |
---|
Themen: |
Extra-analytical phase |
---|
Anmerkungen: |
Date Completed 26.01.2021 Date Revised 16.03.2022 published: Print Citation Status MEDLINE |
---|
doi: |
10.11613/BM.2020.020502 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM311295894 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM311295894 | ||
003 | DE-627 | ||
005 | 20231225141940.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.11613/BM.2020.020502 |2 doi | |
028 | 5 | 2 | |a pubmed24n1037.xml |
035 | |a (DE-627)NLM311295894 | ||
035 | |a (NLM)32550813 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Mrazek, Cornelia |e verfasserin |4 aut | |
245 | 1 | 0 | |a Errors within the total laboratory testing process, from test selection to medical decision-making - A review of causes, consequences, surveillance and solutions |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.01.2021 | ||
500 | |a Date Revised 16.03.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Croatian Society of Medical Biochemistry and Laboratory Medicine. | ||
520 | |a Laboratory analyses are crucial for diagnosis, follow-up and treatment decisions. Since mistakes in every step of the total testing process may potentially affect patient safety, a broad knowledge and systematic assessment of laboratory errors is essential for future improvement. In this review, we aim to discuss the types and frequencies of potential errors in the total testing process, quality management options, as well as tentative solutions for improvement. Unlike most currently available reviews on this topic, we also include errors in test-selection, reporting and interpretation/action of test results. We believe that laboratory specialists will need to refocus on many process steps belonging to the extra-analytical phases, intensifying collaborations with clinicians and supporting test selection and interpretation. This would hopefully lead to substantial improvements in these activities, but may also bring more value to the role of laboratory specialists within the health care setting | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a extra-analytical phase | |
650 | 4 | |a laboratory medicine | |
650 | 4 | |a patient safety | |
650 | 4 | |a quality indicators | |
650 | 4 | |a total testing process | |
700 | 1 | |a Lippi, Giuseppe |e verfasserin |4 aut | |
700 | 1 | |a Keppel, Martin H |e verfasserin |4 aut | |
700 | 1 | |a Felder, Thomas K |e verfasserin |4 aut | |
700 | 1 | |a Oberkofler, Hannes |e verfasserin |4 aut | |
700 | 1 | |a Haschke-Becher, Elisabeth |e verfasserin |4 aut | |
700 | 1 | |a Cadamuro, Janne |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Biochemia medica |d 1997 |g 30(2020), 2 vom: 15. Juni, Seite 020502 |w (DE-627)NLM095507043 |x 1846-7482 |7 nnns |
773 | 1 | 8 | |g volume:30 |g year:2020 |g number:2 |g day:15 |g month:06 |g pages:020502 |
856 | 4 | 0 | |u http://dx.doi.org/10.11613/BM.2020.020502 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 30 |j 2020 |e 2 |b 15 |c 06 |h 020502 |